Kobayashi Pharmaceutical Co Stock Total Asset
Kobayashi Pharmaceutical Co fundamentals help investors to digest information that contributes to Kobayashi Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Kobayashi Pink Sheet. The fundamental analysis module provides a way to measure Kobayashi Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kobayashi Pharmaceutical pink sheet.
Kobayashi |
Kobayashi Pharmaceutical Co Company Total Asset Analysis
Kobayashi Pharmaceutical's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Kobayashi Pharmaceutical Total Asset | 252.55 B |
Most of Kobayashi Pharmaceutical's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kobayashi Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Kobayashi Pharmaceutical Co has a Total Asset of 252.55 B. This is much higher than that of the Consumer Defensive sector and significantly higher than that of the Household & Personal Products industry. The total asset for all United States stocks is significantly lower than that of the firm.
Kobayashi Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kobayashi Pharmaceutical's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kobayashi Pharmaceutical could also be used in its relative valuation, which is a method of valuing Kobayashi Pharmaceutical by comparing valuation metrics of similar companies.Kobayashi Pharmaceutical is currently under evaluation in total asset category among its peers.
Kobayashi Fundamentals
Return On Equity | 0.0968 | |||
Return On Asset | 0.0633 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.16 % | |||
Current Valuation | 3.94 B | |||
Shares Outstanding | 76.01 M | |||
Shares Owned By Insiders | 34.50 % | |||
Shares Owned By Institutions | 21.77 % | |||
Price To Earning | 34.29 X | |||
Price To Book | 2.85 X | |||
Price To Sales | 0.03 X | |||
Revenue | 155.25 B | |||
Gross Profit | 88.77 B | |||
EBITDA | 32.49 B | |||
Net Income | 19.71 B | |||
Cash And Equivalents | 116.15 B | |||
Total Debt | 596 M | |||
Debt To Equity | 0 % | |||
Current Ratio | 3.92 X | |||
Book Value Per Share | 2,653 X | |||
Cash Flow From Operations | 22.42 B | |||
Earnings Per Share | 1.94 X | |||
Number Of Employees | 3.45 K | |||
Beta | 0.27 | |||
Market Capitalization | 5.37 B | |||
Total Asset | 252.55 B | |||
Z Score | 5.4 | |||
Annual Yield | 0.01 % | |||
Net Asset | 252.55 B | |||
Last Dividend Paid | 84.0 |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |